A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma
Clinical trial NCT05908786 · COMPLETED
Trial details
- NCT number
- NCT05908786
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-05
- Primary completion
- 2025-08-27
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.